Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-03-28 @ 9:58 AM
Study NCT ID:
NCT01762150
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2012-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma
Sponsor:
Peking University Cancer Hospital & Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BCH-RCC-120601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |